nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Gadofosveset trisodium—ALB—chronic obstructive pulmonary disease	0.0146	1	CrCbGaD
Gadoxetate—SLCO1B3—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.00233	0.0418	CbGpPWpGaD
Gadoxetate—SLCO1B3—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00173	0.031	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00173	0.0309	CbGpPWpGaD
Gadoxetate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00184	CcSEcCtD
Gadoxetate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00183	CcSEcCtD
Gadoxetate—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00181	CcSEcCtD
Gadoxetate—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00181	CcSEcCtD
Gadoxetate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00181	CcSEcCtD
Gadoxetate—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00178	CcSEcCtD
Gadoxetate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00178	CcSEcCtD
Gadoxetate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00178	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00176	CcSEcCtD
Gadoxetate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00176	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Gadoxetate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Gadoxetate—Cough—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Gadoxetate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00174	CcSEcCtD
Gadoxetate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00174	CcSEcCtD
Gadoxetate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00174	CcSEcCtD
Gadoxetate—Cough—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00172	CcSEcCtD
Gadoxetate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00172	CcSEcCtD
Gadoxetate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00171	CcSEcCtD
Gadoxetate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.0017	CcSEcCtD
Gadoxetate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.0017	CcSEcCtD
Gadoxetate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.0017	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.0017	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00158	0.0017	CcSEcCtD
Gadoxetate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00169	CcSEcCtD
Gadoxetate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00169	CcSEcCtD
Gadoxetate—SLCO1B1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.00157	0.0281	CbGpPWpGaD
Gadoxetate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00168	CcSEcCtD
Gadoxetate—ABCC3—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00156	0.0279	CbGpPWpGaD
Gadoxetate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Gadoxetate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Gadoxetate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00167	CcSEcCtD
Gadoxetate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00167	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00166	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00166	CcSEcCtD
Gadoxetate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00166	CcSEcCtD
Gadoxetate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Gadoxetate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Gadoxetate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Gadoxetate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Gadoxetate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00163	CcSEcCtD
Gadoxetate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00163	CcSEcCtD
Gadoxetate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00162	CcSEcCtD
Gadoxetate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Gadoxetate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Gadoxetate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Gadoxetate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Gadoxetate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00161	CcSEcCtD
Gadoxetate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00161	CcSEcCtD
Gadoxetate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00161	CcSEcCtD
Gadoxetate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.0016	CcSEcCtD
Gadoxetate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00149	0.0016	CcSEcCtD
Gadoxetate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.0016	CcSEcCtD
Gadoxetate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00148	0.0016	CcSEcCtD
Gadoxetate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00159	CcSEcCtD
Gadoxetate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00159	CcSEcCtD
Gadoxetate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.00159	CcSEcCtD
Gadoxetate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00158	CcSEcCtD
Gadoxetate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00158	CcSEcCtD
Gadoxetate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00157	CcSEcCtD
Gadoxetate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00157	CcSEcCtD
Gadoxetate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00156	CcSEcCtD
Gadoxetate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Gadoxetate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Gadoxetate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00154	CcSEcCtD
Gadoxetate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Gadoxetate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Gadoxetate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00152	CcSEcCtD
Gadoxetate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00152	CcSEcCtD
Gadoxetate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.00152	CcSEcCtD
Gadoxetate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00152	CcSEcCtD
Gadoxetate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00151	CcSEcCtD
Gadoxetate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.0015	CcSEcCtD
Gadoxetate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.0015	CcSEcCtD
Gadoxetate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.0015	CcSEcCtD
Gadoxetate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00148	CcSEcCtD
Gadoxetate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00147	CcSEcCtD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00137	0.0245	CbGpPWpGaD
Gadoxetate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00146	CcSEcCtD
Gadoxetate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00146	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00145	CcSEcCtD
Gadoxetate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00145	CcSEcCtD
Gadoxetate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Gadoxetate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Gadoxetate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00143	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00142	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00142	CcSEcCtD
Gadoxetate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00141	CcSEcCtD
Gadoxetate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00141	CcSEcCtD
Gadoxetate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0013	0.0014	CcSEcCtD
Gadoxetate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.0014	CcSEcCtD
Gadoxetate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00139	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00139	CcSEcCtD
Gadoxetate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00139	CcSEcCtD
Gadoxetate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00138	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00137	CcSEcCtD
Gadoxetate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00137	CcSEcCtD
Gadoxetate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00137	CcSEcCtD
Gadoxetate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00136	CcSEcCtD
Gadoxetate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00136	CcSEcCtD
Gadoxetate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Gadoxetate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Gadoxetate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Gadoxetate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00135	CcSEcCtD
Gadoxetate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00135	CcSEcCtD
Gadoxetate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00134	CcSEcCtD
Gadoxetate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00134	CcSEcCtD
Gadoxetate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00131	CcSEcCtD
Gadoxetate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00121	0.0013	CcSEcCtD
Gadoxetate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00129	CcSEcCtD
Gadoxetate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Gadoxetate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Gadoxetate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Gadoxetate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Gadoxetate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00128	CcSEcCtD
Gadoxetate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Gadoxetate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Gadoxetate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Gadoxetate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Gadoxetate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00125	CcSEcCtD
Gadoxetate—SLCO1B1—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00116	0.0208	CbGpPWpGaD
Gadoxetate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Gadoxetate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Gadoxetate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Gadoxetate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00121	CcSEcCtD
Gadoxetate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00121	CcSEcCtD
Gadoxetate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00121	CcSEcCtD
Gadoxetate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.0012	CcSEcCtD
Gadoxetate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Gadoxetate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00118	CcSEcCtD
Gadoxetate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00118	CcSEcCtD
Gadoxetate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Gadoxetate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Gadoxetate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00107	0.00115	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00106	0.0191	CbGpPWpGaD
Gadoxetate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Gadoxetate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Gadoxetate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Gadoxetate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Gadoxetate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Gadoxetate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Gadoxetate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Gadoxetate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Gadoxetate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00101	0.0182	CbGpPWpGaD
Gadoxetate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Gadoxetate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Gadoxetate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000988	0.00106	CcSEcCtD
Gadoxetate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000985	0.00106	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000982	0.0176	CbGpPWpGaD
Gadoxetate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00097	0.00104	CcSEcCtD
Gadoxetate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00097	0.00104	CcSEcCtD
Gadoxetate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00103	CcSEcCtD
Gadoxetate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00103	CcSEcCtD
Gadoxetate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00103	CcSEcCtD
Gadoxetate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00103	CcSEcCtD
Gadoxetate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00103	CcSEcCtD
Gadoxetate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00103	CcSEcCtD
Gadoxetate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000954	0.00103	CcSEcCtD
Gadoxetate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.00102	CcSEcCtD
Gadoxetate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00095	0.00102	CcSEcCtD
Gadoxetate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000942	0.00101	CcSEcCtD
Gadoxetate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000941	0.00101	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000939	0.00101	CcSEcCtD
Gadoxetate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000936	0.00101	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000928	0.000998	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000923	0.0165	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000923	0.0165	CbGpPWpGaD
Gadoxetate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000922	0.000992	CcSEcCtD
Gadoxetate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000916	0.000985	CcSEcCtD
Gadoxetate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000913	0.000982	CcSEcCtD
Gadoxetate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000909	0.000978	CcSEcCtD
Gadoxetate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.000977	CcSEcCtD
Gadoxetate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000908	0.000976	CcSEcCtD
Gadoxetate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.000976	CcSEcCtD
Gadoxetate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000906	0.000974	CcSEcCtD
Gadoxetate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000906	0.000974	CcSEcCtD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000903	0.0162	CbGpPWpGaD
Gadoxetate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00097	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000889	0.000957	CcSEcCtD
Gadoxetate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000887	0.000954	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000879	0.0158	CbGpPWpGaD
Gadoxetate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000877	0.000943	CcSEcCtD
Gadoxetate—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000864	0.0155	CbGpPWpGaD
Gadoxetate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.00092	CcSEcCtD
Gadoxetate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000851	0.000916	CcSEcCtD
Gadoxetate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00083	0.000893	CcSEcCtD
Gadoxetate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000826	0.000888	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000826	0.000888	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000822	0.0147	CbGpPWpGaD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000814	0.0146	CbGpPWpGaD
Gadoxetate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000813	0.000874	CcSEcCtD
Gadoxetate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.000867	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000801	0.0144	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000798	0.000859	CcSEcCtD
Gadoxetate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000784	0.000843	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000778	0.014	CbGpPWpGaD
Gadoxetate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000766	0.000824	CcSEcCtD
Gadoxetate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000763	0.000821	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000755	0.000812	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.000798	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000722	0.0129	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000714	0.0128	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.0007	0.0125	CbGpPWpGaD
Gadoxetate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000693	0.000745	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000682	0.000734	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000681	0.000732	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000679	0.0122	CbGpPWpGaD
Gadoxetate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000676	0.000727	CcSEcCtD
Gadoxetate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000663	0.000713	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000661	0.000711	CcSEcCtD
Gadoxetate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000659	0.000709	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000658	0.0118	CbGpPWpGaD
Gadoxetate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.000706	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000695	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000644	0.0115	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00064	0.0115	CbGpPWpGaD
Gadoxetate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000637	0.000685	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000624	0.000671	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000622	0.000669	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000619	0.000665	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000609	0.000655	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000607	0.0109	CbGpPWpGaD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000606	0.0109	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000605	0.0109	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000602	0.0108	CbGpPWpGaD
Gadoxetate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.0006	0.000646	CcSEcCtD
Gadoxetate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.0006	0.000646	CcSEcCtD
Gadoxetate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000596	0.000641	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000595	0.0107	CbGpPWpGaD
Gadoxetate—Shock—Prednisone—chronic obstructive pulmonary disease	0.00059	0.000635	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000589	0.000633	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000586	0.00063	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000583	0.000627	CcSEcCtD
Gadoxetate—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000581	0.0104	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00058	0.000624	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000573	0.0103	CbGpPWpGaD
Gadoxetate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000615	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00057	0.0102	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000559	0.01	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000555	0.00994	CbGpPWpGaD
Gadoxetate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.000587	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00058	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000538	0.00964	CbGpPWpGaD
Gadoxetate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000522	0.000561	CcSEcCtD
Gadoxetate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.00056	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.00056	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000557	CcSEcCtD
Gadoxetate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.000557	CcSEcCtD
Gadoxetate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000552	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000511	0.00915	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000507	0.00909	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000495	0.000532	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000491	0.000528	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000491	0.000528	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000485	0.00869	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000481	0.00862	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000479	0.00859	CbGpPWpGaD
Gadoxetate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000513	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000474	0.00051	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000474	0.00051	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000472	0.00846	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000472	0.00845	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000455	0.00815	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000449	0.00804	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000443	0.00793	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000442	0.00793	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000442	0.000476	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000431	0.000463	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000427	0.00766	CbGpPWpGaD
Gadoxetate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000457	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000424	0.00759	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000422	0.00756	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000416	0.00746	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000412	0.00739	CbGpPWpGaD
Gadoxetate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000442	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000409	0.00734	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000405	0.00726	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.000404	0.00725	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000399	0.00715	CbGpPWpGaD
Gadoxetate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000427	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000388	0.00695	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.000386	0.00692	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.000385	0.0069	CbGpPWpGaD
Gadoxetate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000382	0.00041	CcSEcCtD
Gadoxetate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000407	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000407	CcSEcCtD
Gadoxetate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000404	CcSEcCtD
Gadoxetate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000383	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000356	0.00638	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000351	0.00629	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000327	0.00586	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000306	0.00548	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000297	0.00533	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000279	0.00499	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000276	0.00494	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000265	0.00476	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000256	0.00458	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000244	0.00437	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000243	0.00436	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000218	0.00391	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000211	0.00378	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000205	0.00368	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000203	0.00363	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.0036	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	0.000197	0.00353	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000197	0.00353	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000189	0.00339	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000186	0.00333	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000183	0.00328	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000183	0.00327	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00325	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00018	0.00322	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000179	0.00321	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GC—chronic obstructive pulmonary disease	0.000178	0.00319	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000171	0.00306	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000168	0.00301	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000165	0.00296	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000158	0.00283	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000157	0.00282	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000146	0.00262	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00262	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000142	0.00254	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.00244	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00242	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000133	0.00239	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000133	0.00239	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000132	0.00237	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00236	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000125	0.00224	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000124	0.00221	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000123	0.00221	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000122	0.00219	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.00012	0.00215	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000113	0.00203	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000112	0.00201	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00011	0.00197	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000108	0.00193	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000106	0.00191	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000106	0.00189	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.92e-05	0.00178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.8e-05	0.00176	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.71e-05	0.00174	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	9.71e-05	0.00174	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.6e-05	0.00172	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.43e-05	0.00169	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.26e-05	0.00166	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	9.24e-05	0.00166	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.95e-05	0.0016	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.94e-05	0.0016	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.84e-05	0.00158	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.76e-05	0.00157	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.51e-05	0.00153	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.07e-05	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8e-05	0.00143	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.46e-05	0.00134	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.36e-05	0.00132	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.23e-05	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.15e-05	0.00128	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.85e-05	0.00123	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.75e-05	0.00121	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.73e-05	0.00121	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.66e-05	0.00119	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.64e-05	0.00119	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.52e-05	0.00117	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.5e-05	0.00116	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.37e-05	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.34e-05	0.00114	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.00111	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.01e-05	0.00108	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.00105	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.85e-05	0.00105	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.01e-05	0.000898	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.94e-05	0.000886	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	4.81e-05	0.000863	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.61e-05	0.000825	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	4.42e-05	0.000792	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.000783	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.23e-05	0.000757	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	3.99e-05	0.000714	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-05	0.000683	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.97e-05	0.000532	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.84e-05	0.000509	CbGpPWpGaD
